Product Information
ROPINIROLE HCL 3 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0806 per EA under NDC 43547027250. Its NADAC has been published 204 times since Sep 28, 2022.
FDA first approved this application on May 5, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547027250
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078110FDA Approved
5/5/2008
TE Code
AB
On Market Since
9/20/2011
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 3 MG TABLET has been published 204 times since Sep 28, 2022, and over the history we have for it it has risen 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0806 per EA |
|---|---|
| All-time high | $0.1067 (Jan 11, 2023) |
| All-time low | $0.0575 (Nov 20, 2024) |
| 52-week high | $0.0848 |
| 52-week low | $0.0795 |
| Median price | $0.0804 |
| Average price | $0.0813 |
| Largest weekly change | +33.6% (Feb 22, 2023) |
| Weeks tracked | 204 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 3 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0806 per EA (NDC 43547027250), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 3 MG TABLET has risen 8.7%. It has been tracked across 204 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 3 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL 3 MG TABLET has ranged from a low of $0.0575 (Nov 20, 2024) to a high of $0.1067 (Jan 11, 2023), with a median of $0.0804 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 3 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 3 MG TABLET?
ROPINIROLE HCL 3 MG TABLET (NDC 43547027250) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.